Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference29 articles.
1. Vicent MJ, Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol. 2006;24(1):39–47.
2. Hurrell T, Outhoff K. The in vitro influences of epidermal growthfactor and heregulin-β1 on the efficacy of trastuzumab used in Her-2positive breast adenocarcinoma. Cancer Cell Int. 2013;13:97.
3. Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol. 2005;23:4265–74.
4. National Comprehensive Cancer Network (NCCN): Breast Cancer Guidelines.
5. Datko F, D'Andrea G, Dickler M, Theodoulou M, Goldfarb S, Lake D, et al. Abstract P5-18-20: phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer. Cancer Res. 2012;72(24 Suppl):18–20.
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献